NCT07258758

Brief Summary

The overall objective for this project is to evaluate the effects of a person-centred education intervention to promote a healthy, sustainable Nordic diet compared with the current practice of providing short dietary information on health outcomes of adults with Type 1 diabetes. The study will measure the intervention's impact on blood glucose levels, blood lipids, blood pressure, and adherence to a sustainable and healthy Nordic diet. The main question the trial aims to answer is: Does a person-centred nutritional education have an impact on glucose time in range for adults with Type 1 diabetes, compared with short dietary information? The participants will:

  • Attend either a person-centred nutrition education (intervention) or receive short dietary information (control group).
  • Wear their sensor for continuous glucose monitoring (CGM) throughout the trial.
  • Visit the clinic for data collection (blood samples and clinical checks) at the start and end of the trial.
  • Keep a four-day food diary, fill out a food frequency questionnaire (FFQ) and estimate their food enjoyment at the start and end of the trial.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
13mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Sep 2025Jun 2027

Study Start

First participant enrolled

September 1, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 20, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 2, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

December 12, 2025

Status Verified

December 1, 2025

Enrollment Period

1.7 years

First QC Date

November 20, 2025

Last Update Submit

December 4, 2025

Conditions

Keywords

Nutritional educationPerson-centred careNordic dietDiabetes interventionType 1 Diabetes

Outcome Measures

Primary Outcomes (1)

  • Time in range - Percentage of time spent with blood glucose levels between 3.9-10 mmol/l.

    Percentage of time spent with glucose levels between 3.9-10 mmol/l measured with continuous glucose monitor (CGM) over 10-14 days.

    Week 1, 12 and 24.

Secondary Outcomes (6)

  • Adherence to a Nordic diet.

    Week 1 and 24.

  • Glycosylated Hemoglobin (HbA1c).

    Week 1 and 24.

  • Time above range - percentage of time spent with blood glucose levels above 10.0 mmol/L and 13.9 mmol/L respectively.

    Week 1, 12 and 24.

  • Time below range - percentage of time spent with blood glucose levels below 3.9 mmol/L and 3.0 mmol/L respectively.

    Week 1, 12 and 24.

  • Blood lipids.

    Week 1 and 24.

  • +1 more secondary outcomes

Study Arms (2)

Person-centred nutritional education

EXPERIMENTAL

The participants in this arm will attend a person-centred intervention involving a pre-assessment focused on creating partnership in care. This is followed by a nutrition education session on the healthy Nordic diet, and a series of follow-up measures.

Behavioral: Dietary intervention

Short dietary information

NO INTERVENTION

The participants in this arm will receive short dietary information (brochure) at the same level as standard care.

Interventions

A person-centred education focussed on creating partnerships in care and shared decision-making.

Person-centred nutritional education

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 1 Diabetes.
  • Diabetes duration for more than 12 months at screening.
  • Adults 18 years or older.
  • HbA1c more than 57mmol/mol.
  • Use of continuous glucose monitoring (CGM) sensor for more than three months at screening and during the study period.
  • Use of basal and bolus insulin regimen for more than three months at screening and during the study period.
  • Written Informed Consent.

You may not qualify if:

  • Women of childbearing potential: ongoing pregnancy or planned pregnancy during the study period.
  • Cognitive impairment or other disease that study physician find non-compatible with participation.
  • Planned change in glucose lowering treatment during study period (change of mealtime insulin analogue with same pharmacodynamic profile allowed).
  • Planned change of CGM sensor during the study.
  • Food allergies or intolerances that are incompatible with adhering to Nordic nutrition recommendations.
  • Current or planned treatment with corticosteroids during the study (other than for replacement therapy).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital of Enköping

Enköping, Uppland, 74525, Sweden

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Interventions

Diet Therapy

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Nutrition TherapyTherapeutics

Study Officials

  • Elisabeth Stoltz Sjöström, Associate professor

    Department of Food, Nutrition and Culinary Science, Umeå University, Sweden

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sophie Rodebjer Cairns, Registered dietitian

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
As the participants are actively involved in the education intervention, it is not possible to have a blinded trial, however each group will not receive information about the alternative group.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized parallel group study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 20, 2025

First Posted

December 2, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

December 12, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations